CATALOGO DEI PRODOTTI DELLA RICERCA

OPPICI, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.260
EU - Europa 1.890
AS - Asia 1.650
SA - Sud America 206
Continente sconosciuto - Info sul continente non disponibili 61
AF - Africa 41
OC - Oceania 1
Totale 6.109
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.208
RU - Federazione Russa 789
CN - Cina 626
SG - Singapore 558
GB - Regno Unito 376
IT - Italia 187
BR - Brasile 166
VN - Vietnam 148
HK - Hong Kong 129
SE - Svezia 108
FR - Francia 86
DE - Germania 85
IE - Irlanda 78
FI - Finlandia 62
KR - Corea 50
IN - India 30
CA - Canada 29
BE - Belgio 23
JP - Giappone 22
UA - Ucraina 21
BD - Bangladesh 18
NL - Olanda 16
ID - Indonesia 15
ES - Italia 14
AR - Argentina 13
NG - Nigeria 13
IQ - Iraq 12
PL - Polonia 12
EC - Ecuador 9
TR - Turchia 9
ZA - Sudafrica 9
MX - Messico 8
PK - Pakistan 8
VE - Venezuela 6
AT - Austria 5
GR - Grecia 5
LT - Lituania 5
PH - Filippine 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
CR - Costa Rica 3
IL - Israele 3
JM - Giamaica 3
KE - Kenya 3
MA - Marocco 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
UY - Uruguay 3
UZ - Uzbekistan 3
BG - Bulgaria 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
LV - Lettonia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BO - Bolivia 1
CG - Congo 1
CM - Camerun 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GL - Groenlandia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
OM - Oman 1
PR - Porto Rico 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 6.050
Salva come PNG Salva come JPEG
Città #
Southend 313
Singapore 290
Moscow 254
Chandler 251
Dallas 246
Ashburn 227
San Jose 191
Woodbridge 138
Ann Arbor 132
Beijing 126
Hong Kong 126
Verona 110
Jacksonville 106
Dublin 78
Council Bluffs 71
The Dalles 59
Jinan 52
New York 48
Ho Chi Minh City 42
Houston 40
Nanjing 38
Los Angeles 34
Lawrence 33
Princeton 33
Shenyang 32
Hanoi 31
Hebei 30
Wilmington 29
Columbus 23
Tianjin 23
Haikou 21
Seattle 21
São Paulo 21
Brussels 20
Zhengzhou 20
Tokyo 19
Ningbo 18
Santa Clara 18
Buffalo 17
Helsinki 17
Changsha 16
Seoul 16
Munich 15
Milan 14
Montreal 14
Nanchang 14
Taizhou 14
Dong Ket 13
Hangzhou 13
Guangzhou 12
Lanzhou 12
Abuja 11
Jakarta 11
Redondo Beach 11
San Francisco 11
Stockholm 11
Belo Horizonte 10
Boardman 10
Chennai 10
Brooklyn 9
Fuzhou 9
Jiaxing 9
Taiyuan 9
Warsaw 8
Amsterdam 7
Da Nang 7
Denver 7
Kent 7
London 7
Norwalk 7
Orem 7
Phoenix 7
Frankfurt am Main 6
Johannesburg 6
Redwood City 6
Boston 5
Dearborn 5
Mumbai 5
Quito 5
Redmond 5
Athens 4
Atlanta 4
Biên Hòa 4
Cagliari 4
Chicago 4
Falkenstein 4
Lancaster 4
Madrid 4
Perugia 4
Qingdao 4
Rio de Janeiro 4
Riva 4
Rome 4
Toronto 4
Auburn Hills 3
Baghdad 3
Berlin 3
Caserta 3
Detroit 3
Erbil 3
Totale 3.853
Salva come PNG Salva come JPEG
Nome #
Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase 308
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 264
Molecular and cellular insights into defects of human alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I 226
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 226
Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine 207
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 205
A novel pathway for metabolism of the cardiovascular risk factor homoarginine by alanine:glyoxylate aminotransferase 2 205
Gain-of-function mutant p53 enhances mitochondrial ROS through the inhibition of PGC-1α/UCP2 axis in cancer cells 205
Caenorhabditis elegans AGXT-1 is a mitochondrial and temperature-adapted ortholog of peroxisomal human AGT1: New insights into between-species divergence in glyoxylate metabolism 202
Folding defects leading to primary hyperoxaluria 202
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 198
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 196
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 195
Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications 195
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells 187
Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview. 183
Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6 180
Dimerization drives proper folding of human Alanine:Glyoxylate aminotransferase but is dispensable for peroxisomal targeting 175
The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I 174
Metastatic breast cancer cells enter into dormant state and express cancer stem cells phenotype under chronic hypoxia 174
Evolutionary divergent suppressor mutations in conformational diseases 172
Biochemical properties and oxalate-degrading activity of oxalate decarboxylase from Bacillus Subtilis at neutral pH 170
S81 L and G170R mutations causing Primary Hyperoxaluria Type I in homozygosis and heterozygosis: an example of positive interallelic complementation. 168
Tat-mediated delivery of human alanine:glyoxylate aminotransferase in a cellular model of Primary Hyperoxaluria Type I 166
Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses 160
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 158
Natural and unnatural compounds rescue folding defects of human alanine:glyoxylate aminotransferase leading to Primary Hyperoxaluria Type I 158
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 154
Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I 154
Molecular basis of primary hyperoxaluria: clues to innovative treatments 150
A novel p.(Glu111Val) missense mutation in GUCA1A associated with cone-rod dystrophy leads to impaired calcium sensing and perturbed second messenger homeostasis in photoreceptors 143
Molecular insights into primary hyperoxaluria Type I pathogenesis. 126
Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I. 123
Totale 6.109
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.249
article - articoli 17.349
book - libri 0
conference - conferenze 726
curatela - curatele 0
other - altro 585
patent - brevetti 0
selected - selezionate 0
volume - volumi 589
Totale 38.498
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022169 0 0 28 9 7 3 6 20 16 8 12 60
2022/2023660 40 88 54 118 62 135 15 41 70 1 21 15
2023/2024262 16 13 11 15 30 50 5 35 5 15 48 19
2024/2025842 41 49 22 138 69 31 66 29 150 51 74 122
2025/20262.595 176 95 285 370 685 198 204 131 194 161 34 62
2026/202761 22 39 0 0 0 0 0 0 0 0 0 0
Totale 6.109